Overview Financials News + Filings Key Docs Ownership Insiders
|
Sensei Biotherapeutics, Inc.
|
|
Balance Sheet |
|
|
|
Standardized | As Reported |
Annual | Quarterly |
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| 10-Q | 10-Q | | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
Assets |
Cash and equivalents | 10.2 | 8.1 | | 11.5 | 9.9 | 8.7 | 7.2 | 9.5 |
Short-term investments | 68.6 | 87.4 | | 105.1 | 113.8 | 127.5 | | 147.1 |
Other current assets | 2.2 | 3.1 | | 1.9 | 3.8 | 2.8 | 141.4 | 1.5 |
Total current assets | 81.1 | 98.6 | | 118.5 | 127.5 | 139.0 | 148.5 | 158.2 |
Property, plant, and equipment, net | 1.5 | 1.8 | | 2.2 | 2.1 | 2.2 | 4.6 | 3.1 |
Other fixed assets | 0.1 | 0.1 | | 0.0 | 0.0 | 0.0 | 0.0 | |
Total assets | 89.6 | 107.9 | | 128.8 | 138.0 | 150.0 | 153.2 | 161.2 |
|
Accrued expenses | 0.7 | 0.6 | | 1.8 | 1.0 | 0.6 | 1.8 | 1.6 |
Short-term debt | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Other current liabilities | 4.6 | 7.0 | | 6.7 | 4.4 | 7.0 | 3.1 | 3.6 |
Total current liabilities | 5.4 | 7.6 | | 8.5 | 5.4 | 7.6 | 4.9 | 5.3 |
Other liabilities | 5.0 | 5.5 | | 6.3 | 6.7 | 7.1 | 1.8 | 0.8 |
Total liabilities | 10.4 | 13.1 | | 14.8 | 12.1 | 14.7 | 6.7 | 6.0 |
|
Shareholders' equity [+] | 79.2 | 94.9 | | 114.0 | 125.9 | 135.3 | 146.5 | 155.2 |
Paid-in capital | 297.1 | 303.6 | | 300.8 | 299.3 | 297.8 | 296.0 | 295.1 |
Retained earnings | -217.4 | -208.0 | | -185.6 | -172.1 | -161.6 | -149.2 | -139.8 |
Tangible shareholders' equity | 79.2 | 94.9 | | 114.0 | 125.9 | 135.3 | 146.5 | 155.2 |
|